Form 4: Anebulo Pharmaceuticals Director Kenneth Lin Reports Stock Option Grant

Kenneth Lin, a director at Anebulo Pharmaceuticals, reported the acquisition of stock options in a recent Form 4 filing.

Summary

• Kenneth Lin, a director of Anebulo Pharmaceuticals, Inc., filed a Form 4 with the SEC.
• The filing reports the grant of stock options to Mr. Lin on June 13, 2024.
• He received options to purchase 41,667 shares at an exercise price of $2.10, vesting 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant.
• Additionally, he received options to purchase 2,482 shares at an exercise price of $2.10, vesting on the earlier of November 30, 2024 or the date of the 2024 annual meeting of shareholders.
• Following the reported transaction, Mr. Lin beneficially owns 41,667 and 2,482 stock options directly.
• Mr. Lin has also granted Richard Cunningham or Daniel George of Anebulo Pharmaceuticals, Inc. power of attorney for Section 16 reporting obligations.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of stock options is a standard practice and suggests confidence in the company's future performance, but it's not a major event.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes long-term performance.

Future Outlook

NA

Industry Context

Stock option grants are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and officers in publicly traded companies, particularly in the biotech and pharmaceutical sectors.
• The size of the grant is typical for a director-level position in a company of Anebulo Pharmaceuticals' size and stage of development.
• Vesting schedules are also standard, designed to incentivize long-term commitment and performance.

Stakeholder Impact

• The stock option grant could have a slightly positive impact on shareholder sentiment, as it aligns the director's interests with those of the shareholders.
• There is no immediate impact on employees, customers, suppliers, or creditors.

Key Dates